Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 20 Source: CRO
- €4.1 billion turnover
-
-€121.6 million
profit - 11,500 employees
-
31st Dec 19 Source: CRO
- €4.4 billion turnover
-
€154.4 million
profit - 10,400 employees
- 6 more years available »
Ranking
By Turnover
(€4.1 billion)- 30th in Top Companies
- 8th in Health
- 5th in Pharma
By Employees
(11,500)- 19th in Top Companies
- 4th in Health
- 3rd in Pharma
-
- 11,500
- €4.1 billion
Employees
- Murray S. Kessler CEO/Managing Director
Latest News
- 5:07pm Former Mayo footballer acquires project management firm
- 4:16pm BioNTech aims to develop first mRNA-based malaria vaccine
- 3:29pm ‘Total travesty’: 294 submissions made over plan to tackle challenges against planning proposals
- 2:57pm Aon’s $30bn acquisition of Willis Towers Watson collapses
- 2:47pm SSE to explore production of green hydrogen energy in Ireland